Tissue factor pathway inhibitor response does not correlate with tissue factor-induced disseminated intravascular coagulation and multiple organ dysfunction syndrome in trauma patients

Critical Care Medicine

Volumn 29, Issue 2, 2001, Pages 262-266

  Gando, Satoshi ^a   Nanzaki, Satoshi ^a   Morimoto, Yuji ^a   Ishitani, Toshiteru ^a   Kemmotsu, Osamu ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Disseminated intravascular coagulation; Multiple organ dysfunction syndrome; Outcome; Systemic inflammatory response syndrome; Tissue factor; Tissue factor pathway inhibitor; Trauma

Indexed keywords

TISSUE FACTOR PATHWAY INHIBITOR;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; COHORT ANALYSIS; COMPLEX FORMATION; DISSEMINATED INTRAVASCULAR CLOTTING; FEMALE; FIBRINOLYSIS; HOSPITAL ADMISSION; HUMAN; MALE; MICROVASCULATURE; MULTIPLE ORGAN FAILURE; OUTCOMES RESEARCH; PRIORITY JOURNAL; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THROMBOCYTE COUNT;

EID: 0035116929     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-200102000-00006     Document Type: Article

References (24)

1. Modulators of coagulation. A critical appraisal of their role in sepsis
2. Pathogenesis of disseminated intravascular coagulation in sepsis
3. Soluble thrombomodulin increases in patients with disseminated intravascular coagulation and in those with multiple organ dysfunction syndrome after trauma: Role of neutrophil elastase
4. Participation of tissue factor and thrombin in posttraumatic systemic inflammatory, syndrome
5. Consumptive thrombohemorrhagic disorders
6. Sites of tissue factor pathway inhibitor (TFPI) and tissue factor expression under physiologic and pathologic conditions
7. Depletion of extrinsic pathway inhibitor (EPI) sensitize rabbits to disseminated intravascular coagulation induced with tissue factor: Evidence supporting a physiologic role for EPI as a natural anticoagulant
8. Immunodepletion of extrinsic pathway inhibitor sensitize rabbits to endotoxin-induced intravascular coagulation and the generalized Schwartzman reaction
9. Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody
10. Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock
11. APACHE II: A severity of disease classification system
12. The Abbreviated Injury Scale, 1985. Revision: A condensed chart for clinical use
13. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis
14. An expanded definition of the adult respiratory distress syndrome
15. Expression of tissue factor, thrombomodulin, and E-selectin in baboons with lethal Escherichia coli sepsis
16. Tissue factor and thrombin posttraumatic systemic inflammatory response syndrome
17. Disseminated intravascular coagulation and sustained systemic inflammatory response syndrome predict organ dysfunctions after trauma. Application of clinical decision analysis
18. Regulation of the extrinsic pathway system in health and disease: The role of factor VIIa and tissue factor pathway inhibitor
19. Tissue factor pathway inhibitor and the current concept of blood coagulation
20. Initiation and regulation of tissue factor-dependent blood coagulation
21. Expression of tissue factor pathway inhibitor by cultured endothelial cells in response to inflammatory mediators
22. Effects of recombinant human tissue factor pathway inhibitor on thrombus formation and its in vivo distribution in a rat DIC model
23. Delayed treatment with recombinant human tissue factor pathway inhibitor improves survival in rabbits with Gram-negative peritonitis
24. Tissue factor pathway inhibitor (TFPI) - An update